#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Arterial disorder Mucopolysaccharidosis II Glycogen storage disease type I Alveolar proteinosis Follicle centre lymphoma follicular grade I II – III refractory Retinopathy proliferative Scedosporium infection Congenital leptin deficiency Haemophagocytic lymphohistiocytosis Mitochondrial DNA depletion Endometrial cancer Marginal zone lymphoma recurrent Sarcoidosis Huntington's disease Hereditary angioedema with C1 esterase inhibitor deficiency More trials…

    Learn about Rare Diseases

    Kearns-Sayre syndrome Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment Adrenogenital syndrome – Diagnostics Angelman’s syndrome – Treatment Haemophilia A without inhibitors – Basic Information Osteosarcoma – Treatment Rhabdomyosarcoma recurrent – Treatment Chronic granulomatous disease – Diagnostics Ornithine transcarbamoylase deficiency – Diagnostics Optic glioma – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Aliskiren Etanercept Apg777 Ezabenlimab SEPOFARSEN Pervi-Fus Streptococcus Agalactiae Lithium Carbonate Ptg-Carcik-Cd19 Calcium Chloride Gns561 Cemiplimab Mesenchymal Cells Gen1046 Evencaleucel L-Ascorbic Acid Ferric Carboxymaltose Dexamethasone Phosphate Tiragolumab Bms-986340 More therapies…

    Learn about Your Condition

    Breast cancer male Langerhans cell sarcoma Adenocarcinoma gastric Normal pressure hydrocephalus Intracranial aneurysm Lichen planopilaris B-cell type acute leukaemia Cushing's syndrome Renal impairment Tuberous sclerosis complex Lyme disease Reperfusion injury Cutaneous sarcoidosis Alport's syndrome Migraine More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Fallopian tube cancer

  • Study of Farletuzumab Ecteribulin vs. Chemotherapy for Women with Platinum-resistant High-grade Serous Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Doxorubicin Hydrochloride
    • Farletuzumab Ecteribulin
    • Paclitaxel
    Belgium Italy Spain

  • Study of Pembrolizumab, MK-4830, and Chemotherapy for Patients with High-Grade Serous Ovarian Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Peritoneal cancer index
    • Fallopian tube cancer
    Investigated Drugs:
    • Bevacizumab
    • Mk-4830
    • Carboplatin
    Belgium Italy Poland Spain

  • Study on Treatment for Recurrent Platinum-Sensitive Ovarian, Peritoneal, or Fallopian Tube Cancer Using Carboplatin and Mirvetuximab Soravtansine in Eligible Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Mirvetuximab Soravtansine
    • Prednisolone Acetate
    • Carboplatin
    Belgium Ireland Spain

  • Study of Mirvetuximab Soravtansine compared to standard chemotherapy in women with platinum-resistant advanced ovarian cancer with high folate receptor expression

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Peritoneal sarcoma
    • Fallopian tube cancer
    • Ovarian epithelial cancer
    Investigated Drugs:
    • Mirvetuximab Soravtansine
    • Prednisolone Acetate
    • Doxorubicin Hydrochloride
    France

  • Study of Raludotatug Deruxtecan for Patients with Platinum-resistant High-grade Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

    Not recruiting

    4 1 1 1
    Investigated Diseases:
    • Fallopian tube cancer
    • Malignant peritoneal neoplasm
    • Ovarian cancer
    Investigated Drugs:
    • Doxorubicin Hydrochloride, Liposomal
    • Raludotatug Deruxtecan
    • Paclitaxel
    Czechia Finland France Germany Greece Italy +3
Previous Page
1 … 3 4 5

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!